Conference Details - Overview
Continuing Education Information
Physicians: Physicians’ Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians’ Education Resource designates this educational activity for a maximum of 12.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA category 1 CME credit for the PRA from organizations accredited by the ACCME.
Oncology Practice Reviews
*Part of a PER conference series [ View Series Overview ]
The Westin Tysons Corner
Washington, DC
April 16-17, 2010
Conference Overview
Overview and Purpose
This activity is presented by Physicians’ Education Resource in conjunction with Duke Oncology Network.
Oncology Practice Reviews is a 2-day symposium designed to educate community physicians on the state-of-the-art clinical management of a wide variety of solid and hematologic malignancies. Lectures will highlight cutting-edge information and emerging treatment strategies for specific tumor types, including breast cancer, genitourinary malignancies, lymphoma, gastrointestinal malignancies, lung cancer, multiple myeloma, myelodysplastic syndromes, leukemia, and chronic lymphocytic leukemia, in addition to other special topics unique to each meeting location. To enhance learning, participants will be engaged in solving “real-world” problems through practical, interactive, case-based presentations.
Product Theaters
Industry-led lectures and exhibits will be conducted in conjunction with this event to provide promotional product-specific information on available agents and products in development, respectively.
These optional activities are not certified for CME credit and are not planned or sanctioned by PER.
Target Audience
This educational program is directed toward medical oncologists and hematologists practicing in the community or academic setting who are interested in recent advances in the treatment of solid tumors and hematologic malignancies. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of cancer are also invited to attend.
Learning Objectives
At the conclusion of this symposium, you should be able to:
- Assess the efficacy and safety of targeted agents in the management of patients with solid tumors and hematologic malignancies
- Identify results of recent clinical trials that are currently applicable to the management of patients with solid tumors and hematologic malignancies